350 related articles for article (PubMed ID: 25142507)
1. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway.
Dai W; Zhao J; Tang N; Zeng X; Wu K; Ye C; Shi J; Lu C; Ning B; Zhang J; Lin Y
Liver Int; 2015 Apr; 35(4):1234-43. PubMed ID: 25142507
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT.
Wu K; Ye C; Lin L; Chu Y; Ji M; Dai W; Zeng X; Lin Y
Clin Sci (Lond); 2016 Aug; 130(16):1469-80. PubMed ID: 27226339
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
4. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis.
Zhao J; Tang N; Wu K; Dai W; Ye C; Shi J; Zhang J; Ning B; Zeng X; Lin Y
PLoS One; 2014; 9(10):e108005. PubMed ID: 25303175
[TBL] [Abstract][Full Text] [Related]
6. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
9. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
10. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
[TBL] [Abstract][Full Text] [Related]
11. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.
Choi SS; Omenetti A; Witek RP; Moylan CA; Syn WK; Jung Y; Yang L; Sudan DL; Sicklick JK; Michelotti GA; Rojkind M; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1093-106. PubMed ID: 19815628
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4.
Ge S; Zhang L; Xie J; Liu F; He J; He J; Wang X; Xiang T
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):918-928. PubMed ID: 27740527
[TBL] [Abstract][Full Text] [Related]
15. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
[TBL] [Abstract][Full Text] [Related]
16. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
[TBL] [Abstract][Full Text] [Related]
17. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
[TBL] [Abstract][Full Text] [Related]
19. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
20. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
